.
ISSN 2063-5346
-
BIOCHEMISTRY OF FASTING – A REVIEW ON METABOLIC SWITCH AND AUTOPHAGY.
Volume - 13 | Issue-1
-
ONE-POT ENVIRONMENT FRIENDLY SYNTHESIS OF IMINE DERIVATIVE OF FURFURAL AND ASSESSMENT OF ITS ANTIOXIDANT AND ANTIBACTERIAL POTENTIAL
Volume - 13 | Issue-1
-
MODELING AND ANALYSIS OF MEDIA INFLUENCE OF INFORMATION DIFFUSION ON THE SPREAD OF CORONA VIRUS PANDEMIC DISEASE (COVID-19)
Volume - 13 | Issue-1
-
INCIDENCE OF HISTOPATHOLOGICAL FINDINGS IN APPENDECTOMY SPECIMENS IN A TERTIARY CARE HOSPITAL IN TWO-YEAR TIME
Volume - 13 | Issue-1
-
SEVERITY OF URINARY TRACT INFECTION SYMPTOMS AND THE ANTIBIOTIC RESISTANCE IN A TERTIARY CARE CENTRE IN PAKISTAN
Volume - 13 | Issue-1
Analysis of an Open Labelled Randomized Controlled Trial to Evaluate the Efficacy and Safety of Siddha Supplement (MAM Granules) along with Standard of Care Treatment in the management of RT-PCR Positive Pre-symptomatic COVID-19 patients at COVID-19 Care
Main Article Content
Abstract
COVID-19 emerges as the major global healthcare challenge of this century. In March 2021 during the initiation of the study, there is no proven herbal add-on therapy declared to combat COVID-19. Therefore, based on evidence from Pre-Clinical Studies, we tested the safety and efficacy of polyherbal drugs from India’s one of traditional medical systems i.e. Siddha Medical System namely “MAM Novel Siddha formulation” for the management of COVID-19. These Studies’ outcomes will be useful to explore the appropriate add-on Siddha drug in the management of COVID-19.
Article Details
